Suchergebnisse - "Sun, Yan"

PubPharm (95)

1

Butyrate as a promising therapeutic target in cancer : From pathogenesis to clinic (Review)

enthalten in: International journal of oncology | 2024

von Sun, J. | Chen, S. | Zang, D. | +3

2

Structures, Biosynthesis, and Bioactivity of Oligomycins from the Marine-Derived Streptomyces sp. FXY-T5

enthalten in: Journal of agricultural and food chemistry | 2024

von Feng, X. | Li, J. | Li, R. | +6

3

Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax

enthalten in: International journal of hematology | 2023

von Izutsu, K. | Yamamoto, K. | Kato, K. | +11

CommentOn: Blood. 2022 Aug 25;140(8):839-850. - PMID 35605176

4

Unfair older patients restriction in cancer drug trials in mainland China and corresponding solution

enthalten in: BMC geriatrics | 2023

von Huang, H. | Tang, Y. | Wu, D. | +11

5

The efficacy of small molecule anti-angiogenic drugs in previously treated Thymic carcinoma

enthalten in: BMC cancer | 2023

von Guan, Y. | Gu, X. | Si, J. | +5

6

Versatile activity and morphological effects of zinc oxide submicron particles as anticancer agents

enthalten in: Nanomedicine (London, England) | 2022

von Geng, J. | Jensen, G. | Jackson, K. | +5

7

Impacts of National Drug Price Negotiation on Expenditure, Volume, and Availability of Targeted Anti-Cancer Drugs in China : An Interrupted Time Series Analysis

enthalten in: International journal of environmental research and public health | 2022

von Sun, Y. | Zhu, Z. | Zhang, J. | +4

8

First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer : Results from a Phase I Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Zhang, J. | Ji, D. | Cai, L. | +16

9

MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway

enthalten in: Bioscience reports | 2021

von Yang, Y. | Yang, Z. | Zhang, R. | +10

10

Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

enthalten in: Cancer discovery | 2021

von Pullarkat, V. | Lacayo, N. | Jabbour, E. | +26

CommentIn: Cancer Discov. 2021 Jun;11(6):1324-1326. - PMID 34078661

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]